Charles Schwab Investment Management Inc Maxcyte, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 299,734 shares of MXCT stock, worth $680,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

299,734

Previous 291,980 2.66%

Holding current value

$680,396

Previous $1.21 Million 32.62%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$2.73 - $5.1 $21,168 - $39,545	7,754 Added 2.66%	299,734 $818,000
Q4 2024 Feb 06, 2025	SELL	$3.23 - $4.43 $24,848 - $34,079	-7,693 Reduced 2.57%	291,980 $1.21 Million
Q3 2024 Nov 12, 2024	BUY	$3.68 - $5.06 $2,800 - $3,850	761 Added 0.25%	299,673 $1.17 Million
Q2 2024 Aug 12, 2024	BUY	$3.63 - $5.0 $203,352 - $280,100	56,020 Added 23.06%	298,912 $1.17 Million
Q1 2024 May 08, 2024	SELL	$3.94 - $5.38 $3,352 - $4,578	-851 Reduced 0.35%	242,892 $1.02 Million
Q4 2023 Feb 06, 2024	BUY	$2.6 - $5.24 $13,704 - $27,620	5,271 Added 2.21%	243,743 $1.15 Million
Q2 2023 Aug 09, 2023	SELL	$3.69 - $5.35 $697 - $1,011	-189 Reduced 0.08%	238,472 $1.09 Million
Q1 2023 May 11, 2023	BUY	$4.03 - $5.89 $22,229 - $32,489	5,516 Added 2.37%	238,661 $1.18 Million
Q4 2022 Feb 13, 2023	BUY	$4.92 - $7.4 $15,625 - $23,502	3,176 Added 1.38%	233,145 $1.27 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $175,362 - $252,568	38,797 Added 20.29%	229,969 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$3.59 - $6.81 $113,792 - $215,856	-31,697 Reduced 14.22%	191,172 $905,000
Q1 2022 May 13, 2022	BUY	$5.26 - $10.84 $79,147 - $163,109	15,047 Added 7.24%	222,869 $1.56 Million
Q4 2021 Feb 11, 2022	BUY	$8.87 - $12.94 $1.54 Million - $2.24 Million	173,485 Added 505.24%	207,822 $2.12 Million
Q3 2021 Nov 16, 2021	BUY	$12.21 - $17.2 $419,254 - $590,596	34,337 New	34,337 $420,000

Others Institutions Holding MXCT

# of Institutions

119

Shares Held

73.2M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $231M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Maxcyte, Inc. Transaction History